GraftLife AB
Developing patented ex-vivo perfusion technology to increase transplantable kidneys globally.
Oversigt
- 3
- Medarbejdere
- 1.6mio SEK
- Omsætning
- 2019
- Grundlagt
Nøglebeslutningstagere
Magnus Nilsson
CEO
Beskrivelse
UGLK Science AB is a Swedish biotechnology company focused on solving the critical shortage of transplantable donor kidneys. They have developed a patented ex-vivo kidney perfusion system designed for the reconditioning and evaluation of organs. This innovative system comprises a durable perfusion m...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559194216301
Beslutningstagere
1 kontakter i FunnelfeedrMagnus Nilsson
CEO
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Vitrosorb AB
5–9 medarbejdereSwedish medical device company solving organ transplant barriers.
Vitrosorb Technology AB
Swedish medical device company solving critical healthcare needs via apheresis.
Xvivo Perfusion Aktiebolag
50–99 medarbejdereWorld leader developing technology to extend organ life for transplantation.
Carnamedica AB
0 medarbejderePolish company providing specialized organ perfusion technology for transplant teams.
GLYCOREX TRANSPLANTATION AB (PUBL)
10–19 medarbejdereDevelops technology to remove blood antibodies for transplants and disease.
Udforsk mere
Spørgsmål om GraftLife AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo